Reaction Details Report a problem with these data
Target
Interleukin-2
Ligand
BDBM412387
Substrate
n/a
Meas. Tech.
Human ELISA assay
IC50
12.0±n/a nM
Citation
 Chen, S; Bohnert, G; Jiang, J; Xia, Z Compounds for inflammation and immune-related uses US Patent  US10399967 Publication Date 9/3/2019 
Target
Name:
Interleukin-2
Synonyms:
IL-2 | IL2 | IL2_HUMAN | INN=Aldesleukin | Interleukin-2 | Interleukin-2 (IL-2) | T-cell growth factor | TCGF
Type:
Enzyme
Mol. Mass.:
17630.05
Organism:
Homo sapiens (Human)
Description:
P60568
Residue:
153
Sequence:
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT
  
Inhibitor
Name:
BDBM412387
Synonyms:
N-(2'-chloro-5'-(trifluoromethyl)- [1,1'-biphenyl]-4-yl)-4- methylnicotinamide | US10399967, Compound 17
Type:
Small organic molecule
Emp. Form.:
C20H14ClF3N2O
Mol. Mass.:
390.786
SMILES:
Cc1ccncc1C(=O)Nc1ccc(cc1)-c1cc(ccc1Cl)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: